CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 86 filers reported holding CUREVAC N V in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,954 | +22.1% | 2,190 | +86.2% | 0.00% | – |
| Q2 2023 | $12,248 | +52.6% | 1,176 | +2.0% | 0.00% | – |
| Q1 2023 | $8,028 | +14.7% | 1,153 | -4.9% | 0.00% | – |
| Q4 2022 | $7,000 | -36.4% | 1,213 | -10.0% | 0.00% | – |
| Q3 2022 | $11,000 | -42.1% | 1,348 | -6.9% | 0.00% | – |
| Q2 2022 | $19,000 | -40.6% | 1,448 | -11.0% | 0.00% | – |
| Q1 2022 | $32,000 | -38.5% | 1,627 | +3.6% | 0.00% | – |
| Q4 2021 | $52,000 | -50.0% | 1,570 | -17.4% | 0.00% | – |
| Q3 2021 | $104,000 | +36.8% | 1,900 | +82.7% | 0.00% | – |
| Q2 2021 | $76,000 | -24.0% | 1,040 | -5.2% | 0.00% | – |
| Q1 2021 | $100,000 | +127.3% | 1,097 | +100.9% | 0.00% | – |
| Q4 2020 | $44,000 | -2.2% | 546 | -44.1% | 0.00% | – |
| Q3 2020 | $45,000 | – | 976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $11,332,823 | 10.01% |
| RA Capital Management | 12,245,955 | $85,354,306 | 1.93% |
| Avidity Partners Management LP | 3,550,000 | $24,743,500 | 0.82% |
| Camber Capital Management LP | 1,250,000 | $8,713 | 0.27% |
| Ghisallo Capital Management LLC | 100,000 | $697,000 | 0.17% |
| FOX RUN MANAGEMENT, L.L.C. | 31,278 | $218,008 | 0.07% |
| Alyeska Investment Group, L.P. | 1,060,382 | $7,390,863 | 0.06% |
| Green Alpha Advisors, LLC | 12,351 | $86,086 | 0.06% |
| Virtus ETF Advisers LLC | 14,114 | $98,375 | 0.05% |
| Quantamental Technologies LLC | 11,146 | $77,688 | 0.04% |